QRONO
Qrono, Inc. is a biotechnology corporation. The company focuses on developing cancer tumour treatment therapies.
QRONO
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2010-01-01
Address:
Pittsburgh, Pennsylvania, United States
Country:
United States
Website Url:
http://www.qrono.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
50 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Google Apps For Business GStatic Google Static Content Google Cloud Sectigo SSL
Similar Organizations
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Founder
Investors List
Idea Foundry
Idea Foundry investment in Convertible Note - Qrono
Official Site Inspections
http://www.qrono.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Qrono"
Qrono - Crunchbase Company Profile & Funding
Qrono, Inc. is a biotechnology corporation that develops therapies for treating cancer tumours. New. Resources. Advanced Search ... Experience the new …See details»
Qrono, Inc. Company Profile | Pittsburgh, PA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Qrono, Inc. of Pittsburgh, PA. Get the latest business insights from Dun & Bradstreet.See details»
Qrono Inc. - LinkedIn
Qrono Inc is working on new immunotherapies using our Eloquent platform to target antigen presenting cells and macrophages. Sign up on our website for updates.See details»
Qrono 2025 Company Profile: Valuation, Funding & Investors
Qrono has raised $300K. Who are Qrono’s investors? National Institutes of Health , National Institute Of Allergy and Infectious Diseases, Pittsburgh Life Sciences Greenhouse , U.S. Food …See details»
Qrono Company Profile - Office Locations, Competitors, Revenue …
Qrono has 5 employees at their 1 location. See insights on Qrono including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Qrono - Funding, Financials, Valuation & Investors - Crunchbase
Qrono, Inc. is a biotechnology corporation that develops therapies for treating cancer tumours. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... How much funding has …See details»
Qrono, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Qrono, Inc. with its drug pipeline, therapeutic area, technology platform, 4 literature, Disease Domain:Infectious Diseases, Immune System Diseases ...See details»
Qrono - Contacts, Employees, Board Members, Advisors & Alumni
Qrono, Inc. is a biotechnology corporation that develops therapies for treating cancer tumours.See details»
Targeted Immunotherapy | Qrono | Pittsburgh
Find Out More About How Qrono is Harnessing Antigen Presenting Cells * Name * Email * Subscribe for Updates - Delivery Contact and Address - Christina Cargill, PhD | Head of …See details»
Qrono Inc - VentureRadar
Qrono is transforming the design of long-acting, controlled release formulations from a time consuming, expensive, and risky process based on heuristic experiments to a fast, …See details»
Qrono - Products, Competitors, Financials, Employees, …
Qrono is a biotechnology company focused on the development of targeted immunotherapy treatments. The company specializes in creating immunotherapy drug products that target …See details»
Immunotherapy Company Triggers Immune System To Fight Cancer
Rothstein said that Qrono sold the side of their company that makes long-acting drugs in 2017, which had an annual revenue of between $300,000 and $400,000 per year and re-invested …See details»
Qrono, Inc. | Life Sciences PA
Qrono, Inc. is a biotechnology corporation. The company focuses on developing cancer tumour treatment therapies.See details»
Qrono, Inc. | SBIR.gov
Qrono has created a new drug delivery platform by mathematically optim ... SBIR Phase I 2014 Department of Health and Human Services National Institutes of Health. Development of a …See details»
Qrono - Office of Innovation and Entrepreneurship
Qrono is a specialty pharmaceutical company enabling better medications, stronger patient adherence, improved patient outcomes, and faster time-to-market using an innovative …See details»
Qrono - Overview, News & Similar companies | ZoomInfo.com
Who is Qrono. Qrono is developing a unique pipeline of locally administered immunotherapies for solid tumor cancers. Qronos products reach key targets within tum ors and induce changes in …See details»
Immunotherapy Company Triggers Immune System To Fight Cancer
Jul 28, 2020 Rothstein said that Qrono sold the side of their company that makes long-acting drugs in 2017, which had an annual revenue of between $300,000 and $400,000 per year and …See details»
SBIR-STTR-Success: Immunotherapy Company Triggers Immune …
Jun 23, 2022 The immunotherapy company Qrono didn’t start off hoping to drastically change treatment options for cancer patients, but that is what their goal is today. In 2009, Sam …See details»
Qrono | Eloquent Immunotherapy
Qrono’s Eloquent™ platform uses mathematically optimized polymer particles to start healthy dialogues along conserved pathways by delivering the right amount of agent at the right rate to …See details»
Octreotide - Qrono - AdisInsight - Springer
Qrono is developing QR 107, a controlled release injectable formulation of octreotide, using QronoMetrics™ technology, for the treatment of Cancer. Octreotide ... If your organization has …See details»